XORTX Therapeutics XRTX
NASDAQ XRTX
$1.69 -0.01 (-0.58%)
As of: Sep 30, 2026 · 11:41 AM EDT

XORTX Therapeutics (XRTX) Enterprise Value (2021 - 2026)

Updated

XORTX Therapeutics (XRTX) posted Enterprise Value of $1.06 million for the quarter ended Jun 30, 2026, down 31.3% from $1.54 million a year earlier and down 37.3% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Enterprise Value (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at XORTX Therapeutics was -$1.25 million; for the year ended Dec 31, 2025, it came in at $1.8 million, up 130.6% from the prior year.

  • Annual Enterprise Value shows a four-year compound annual growth rate of -67.8% (years ended Dec 2021 to Dec 2025).
  • In prior years, XORTX Therapeutics' Enterprise Value was $779,073 in the year ended Dec 31, 2024 (-33.4%), $1.17 million in the year ended Dec 31, 2023 (-98.8%), $98.44 million in the year ended Dec 31, 2022 (-40.9%) and $166.64 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Enterprise Value since the quarter ended Mar 31, 2025.
  • On a year-over-year basis, Enterprise Value increased in four of the last eight quarters, with growth averaging 14.7%.
  • The strongest year-over-year quarter for Enterprise Value in the past five years was the quarter ended Dec 31, 2025, with growth of 130.6%; the weakest was the quarter ended Jun 30, 2024, with a decline of 99.1%.
  • According to Business Quant data, Enterprise Value for the three prior quarters was $1.69 million (quarter ended Mar 31, 2026), $1.8 million (quarter ended Dec 31, 2025) and $1.14 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 XORTX Therapeutics 1.62 Mn -1.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.06 Mn
Mar 31, 2026 1.69 Mn
Dec 31, 2025 1.80 Mn
Sep 30, 2025 1.14 Mn
Jun 30, 2025 1.54 Mn
Mar 31, 2025 868,136.51
Dec 31, 2024 779,073.00
Sep 30, 2024 977,366.92
Jun 30, 2024 719,343.00
Mar 31, 2024 3.56 Mn
Dec 31, 2023 1.17 Mn
Sep 30, 2023 76.10 Mn
Jun 30, 2023 81.63 Mn
Mar 31, 2023 54.99 Mn
Dec 31, 2022 98.90 Mn
Sep 30, 2022 97.92 Mn
Jun 30, 2022 114.44 Mn
Mar 31, 2022 160.58 Mn
Dec 31, 2021 166.73 Mn
Sep 30, 2021 293.81 Mn
API Access

XORTX Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=XRTX&period=max&api_key=YOUR_API_KEY